5AWV
Crystal structure of glycopeptide hexose oxidase DBV29 complexed with teicoplanin
「4K3T」から置き換えられました 「2WDX」から置き換えられました5AWV の概要
| エントリーDOI | 10.2210/pdb5awv/pdb |
| 関連するBIRD辞書のPRD_ID | PRD_001065 |
| 分子名称 | Putative hexose oxidase, TEICOPLANIN, FLAVIN-ADENINE DINUCLEOTIDE, ... (9 entities in total) |
| 機能のキーワード | oxidoreductase-antibiotic complex, oxidoreductase/antibiotic |
| 由来する生物種 | Nonomuraea sp. ATCC 39727 詳細 |
| タンパク質・核酸の鎖数 | 12 |
| 化学式量合計 | 247398.17 |
| 構造登録者 | |
| 主引用文献 | Liu, Y.C.,Li, Y.S.,Lyu, S.Y.,Hsu, L.J.,Chen, Y.H.,Huang, Y.T.,Chan, H.C.,Huang, C.J.,Chen, G.H.,Chou, C.C.,Tsai, M.D.,Li, T.L. Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds. Nat. Chem. Biol., 7:304-309, 2011 Cited by PubMed Abstract: In the search for new efficacious antibiotics, biosynthetic engineering offers attractive opportunities to introduce minor alterations to antibiotic structures that may overcome resistance. Dbv29, a flavin-containing oxidase, catalyzes the four-electron oxidation of a vancomycin-like glycopeptide to yield A40926. Structural and biochemical examination of Dbv29 now provides insights into residues that govern flavinylation and activity, protein conformation and reaction mechanism. In particular, the serendipitous discovery of a reaction intermediate in the crystal structure led us to identify an unexpected opportunity to intercept the normal enzyme mechanism at two different points to create new teicoplanin analogs. Using this method, we synthesized families of antibiotic analogs with amidated and aminated lipid chains, some of which showed marked potency and efficacy against multidrug resistant pathogens. This method offers a new strategy for the development of chemical diversity to combat antibacterial resistance. PubMed: 21478878DOI: 10.1038/nchembio.556 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.93 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






